Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-19

Clinical Trial Update: Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing how carbamazepine and oxcarbazepine affect serum neuron-specific enolase and S100B in patients with focal seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)
  • Oxcarbazepine (Oxcarbazepine)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Seizures, Focal | Phase 4 | Status: COMPLETED